The University of Southampton
University of Southampton Institutional Repository

Preoperative Cer(d18:1/24:0) shows promise as a candidate predictor of plasma lipid phenotypes following Roux-en-Y Gastric bypass in women: an exploratory analysis of the SURMetaGIT study

Preoperative Cer(d18:1/24:0) shows promise as a candidate predictor of plasma lipid phenotypes following Roux-en-Y Gastric bypass in women: an exploratory analysis of the SURMetaGIT study
Preoperative Cer(d18:1/24:0) shows promise as a candidate predictor of plasma lipid phenotypes following Roux-en-Y Gastric bypass in women: an exploratory analysis of the SURMetaGIT study
Roux-en-Y gastric bypass (RYGB) surgery is known to improve lipid profiles in individuals with obesity, but the degree of improvement varies. Emerging evidence suggests a role for sphingolipids in modulating cholesterol metabolism. This study investigated the relationship between plasma sphingolipid changes and cholesterol improvements in women with obesity and Type 2 diabetes mellitus (T2DM) following RYGB. Patients from the SURMetaGIT study were evaluated before and 3 months after surgery. Biochemical and sphingolipid analyses, anthropometric measures, and body composition were assessed. A nonhierarchical cluster analysis assessed distinct phenotypes in response to cholesterol after surgery. The p value from multiple comparison tests was adjusted using the false discovery rate (FDR) method. A metabolite fold change [log2 (postoperative mean/preoperative mean)] of 1.2 and an adjusted p value < 5% were considered statistically significant. A linear regression model was used to investigate the relationship between sphingolipids and cholesterol levels. Finally, a binary logistic regression model was developed to identify the predictive value of specific discriminative sphingolipids in the lipid improvement after RYGB. Distinct sphingolipid remodeling patterns were observed, with specific sphingolipids, including Cer(d18:1/24:0), SM(d18:1/22:0), and SM(d18:1/24:0), presenting a strong positive correlation with cholesterol levels, independent of weight loss and T2DM remission. The binary logistic regression showed preoperative Cer(d18:1/24:0) could be the strongest candidate predictor of plasma lipid improvement after surgery (accuracy of 78%; AUC 0.87). These findings suggest that specific sphingolipids, notably preoperative Cer(d18:1/24:0), seemed to have a potential role in predicting cholesterol improvement after RYGB. External validation in independent cohorts is warranted before clinical applicability can be established.
Roux-en-Y gastric bypass, bariatric surgery, cholesterol, metabolomics, sphingolipids
2090-0708
de O. Lemos, Gabriela
19299fbd-88a9-403c-a466-57e50cdc1e32
Torrinhas, Raquel S.M.
badb968f-549c-4276-a296-d9639d513f5f
Volejnik Pino, Jessica M.
ed3f13e5-6322-453f-b399-25afa987acbb
Calder, Philip C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Heymsfield, Steven B.
5b64ce8e-21f6-4fa1-b3a7-57021677b031
Machado, Natasha M.
51c5feed-c332-46e7-b252-1160b11ffbb9
Waitzberg, Dan L.
6de3f90b-010d-48c6-829d-29941329ea97
de O. Lemos, Gabriela
19299fbd-88a9-403c-a466-57e50cdc1e32
Torrinhas, Raquel S.M.
badb968f-549c-4276-a296-d9639d513f5f
Volejnik Pino, Jessica M.
ed3f13e5-6322-453f-b399-25afa987acbb
Calder, Philip C.
1797e54f-378e-4dcb-80a4-3e30018f07a6
Heymsfield, Steven B.
5b64ce8e-21f6-4fa1-b3a7-57021677b031
Machado, Natasha M.
51c5feed-c332-46e7-b252-1160b11ffbb9
Waitzberg, Dan L.
6de3f90b-010d-48c6-829d-29941329ea97

de O. Lemos, Gabriela, Torrinhas, Raquel S.M., Volejnik Pino, Jessica M., Calder, Philip C., Heymsfield, Steven B., Machado, Natasha M. and Waitzberg, Dan L. (2026) Preoperative Cer(d18:1/24:0) shows promise as a candidate predictor of plasma lipid phenotypes following Roux-en-Y Gastric bypass in women: an exploratory analysis of the SURMetaGIT study. Journal of Obesity, 2026 (1), [2335829]. (doi:10.1155/jobe/2335829).

Record type: Article

Abstract

Roux-en-Y gastric bypass (RYGB) surgery is known to improve lipid profiles in individuals with obesity, but the degree of improvement varies. Emerging evidence suggests a role for sphingolipids in modulating cholesterol metabolism. This study investigated the relationship between plasma sphingolipid changes and cholesterol improvements in women with obesity and Type 2 diabetes mellitus (T2DM) following RYGB. Patients from the SURMetaGIT study were evaluated before and 3 months after surgery. Biochemical and sphingolipid analyses, anthropometric measures, and body composition were assessed. A nonhierarchical cluster analysis assessed distinct phenotypes in response to cholesterol after surgery. The p value from multiple comparison tests was adjusted using the false discovery rate (FDR) method. A metabolite fold change [log2 (postoperative mean/preoperative mean)] of 1.2 and an adjusted p value < 5% were considered statistically significant. A linear regression model was used to investigate the relationship between sphingolipids and cholesterol levels. Finally, a binary logistic regression model was developed to identify the predictive value of specific discriminative sphingolipids in the lipid improvement after RYGB. Distinct sphingolipid remodeling patterns were observed, with specific sphingolipids, including Cer(d18:1/24:0), SM(d18:1/22:0), and SM(d18:1/24:0), presenting a strong positive correlation with cholesterol levels, independent of weight loss and T2DM remission. The binary logistic regression showed preoperative Cer(d18:1/24:0) could be the strongest candidate predictor of plasma lipid improvement after surgery (accuracy of 78%; AUC 0.87). These findings suggest that specific sphingolipids, notably preoperative Cer(d18:1/24:0), seemed to have a potential role in predicting cholesterol improvement after RYGB. External validation in independent cohorts is warranted before clinical applicability can be established.

Text
Lemos G.O. et al._Accepted - Accepted Manuscript
Available under License Creative Commons Attribution.
Download (1MB)

More information

Accepted/In Press date: 7 July 2026
e-pub ahead of print date: 12 August 2026
Keywords: Roux-en-Y gastric bypass, bariatric surgery, cholesterol, metabolomics, sphingolipids

Identifiers

Local EPrints ID: 514657
URI: https://eprints.soton.ac.uk/id/eprint/514657
ISSN: 2090-0708
PURE UUID: be4599d8-4faa-4b37-a292-ecc06d00b4a8
ORCID for Philip C. Calder: ORCID iD orcid.org/0000-0002-6038-710X

Catalogue record

Date deposited: 22 Sep 2026 16:43
Last modified: 03 Oct 2026 01:38

Export record

Altmetrics

Contributors

Author: Gabriela de O. Lemos
Author: Raquel S.M. Torrinhas
Author: Jessica M. Volejnik Pino
Author: Steven B. Heymsfield
Author: Natasha M. Machado
Author: Dan L. Waitzberg

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of https://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×